Trials / Conditions / Stage III Anal Cancer AJCC v8
Stage III Anal Cancer AJCC v8
5 registered clinical trials studyying Stage III Anal Cancer AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer NCT04929028 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients NCT04444921 | National Cancer Institute (NCI) | Phase 3 |
| Completed | 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer NCT05130073 | M.D. Anderson Cancer Center | — |
| Completed | Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive NCT03690921 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer NCT03233711 | National Cancer Institute (NCI) | Phase 3 |